donepezil has been researched along with Diabetes Mellitus, Adult-Onset in 6 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alzheimer's disease is the most common cause of dementia in the elderly population." | 1.72 | Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin. ( Ali, RH; Ali, SK, 2022) |
| "Pathogenesis of diabetic encephalopathy (DE) is not completely understood until now." | 1.56 | Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model. ( Li, J; Shi, S; Wang, L; Wang, WP; Wang, XL; Yin, HJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SK | 1 |
| Ali, RH | 1 |
| Shi, S | 1 |
| Yin, HJ | 1 |
| Li, J | 1 |
| Wang, L | 1 |
| Wang, WP | 1 |
| Wang, XL | 1 |
| Gomaa, AA | 1 |
| Makboul, RM | 1 |
| El-Mokhtar, MA | 1 |
| Abdel-Rahman, EA | 1 |
| Ahmed, EA | 1 |
| Nicola, MA | 1 |
| Rahigude, A | 1 |
| Bhutada, P | 1 |
| Kaulaskar, S | 1 |
| Aswar, M | 1 |
| Otari, K | 1 |
| Niwa, H | 1 |
| Koumoto, C | 1 |
| Shiga, T | 1 |
| Takeuchi, J | 1 |
| Mishima, S | 1 |
| Segawa, T | 1 |
| Atsumi, T | 1 |
| Shimizu, C | 1 |
| Koike, T | 1 |
| Yoshioka, N | 1 |
| Kouta, Y | 1 |
| Sakurai, T | 1 |
| Yokono, K | 1 |
1 review available for donepezil and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
[Cognitive dysfunction and dementia associated with elderly diabetes].
Topics: Aged; Antihypertensive Agents; Brain; Cognition Disorders; Dementia; Diabetes Mellitus, Type 2; Done | 2006 |
5 other studies available for donepezil and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Effects of antidiabetic agents on Alzheimer's disease biomarkers in experimentally induced hyperglycemic rat model by streptozocin.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases | 2022 |
Studies of pathology and pharmacology of diabetic encephalopathy with KK-Ay mouse model.
Topics: Animals; Brain Diseases; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Experimental; Diabete | 2020 |
Evaluation of the neuroprotective effect of donepezil in type 2 diabetic rats.
Topics: Alzheimer Disease; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Donepezil; H | 2021 |
Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cholinesterase Inhibitors; Cholinesterases; Diabe | 2012 |
Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT.
Topics: Aged; Brain; Cerebrovascular Circulation; Cholinesterase Inhibitors; Cognition Disorders; Diabetes M | 2006 |